Martin AA, Tomas FM, Owens PC, Knowles SE, Ballard FJ, Read LC: IGF-I and its variant, des-(13)IGF-I, enhance growth in rats with reduced renal mass
By coupling brain-targeted nanocarriers with patient-specific metabolic fingerprints, a gene-matched, pathway-matched strategy is emergingpositioning riboflavin at the center of personalized, systems-level interventions for both rare flavoproteinopathies and common neurodegenerative disorders
Everyone is so kind, helpful and especially knowledgeable
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases